A collaborative study published in Immunity from the Batista Lab and Liu Lab at the Ragon Institute, together with the Schief ...

Janux Therapeutics has dosed the first participant in a Phase I clinical trial of JANX011, a Cluster of Differentiation 19 ...

Researchers at the Ragon Institute and Scripps Research Institute have discovered that antibodies produced during immune responses act as a "brake" on B cell selection, preventing over-optimization ...

The authors found that Csk (a tyrosine kinase that attenuates B cell receptor signaling) is required for germinal center maintenance and efficient antibody maturation. Osaka, Japan – The immune system ...

In a milestone for the hematologic oncology landscape, the first patient has been dosed in a phase 1/2 clinical trial (NCT07220616) evaluating DS3790, a potential first-in-class antibody-drug ...

Multiple sclerosis B-cell profiles differ by ancestry and sex among Black and Hispanic patients with multiple sclerosis.

Technology based on Bracco’s clinically validated microbubble technology enables gentle, scalable cell selection and activation, streamlining workflows for cell therapy Bracco’s microbubbles, an ...